BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30604878)

  • 1. Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web-based survey by the European Network of Uropathology.
    Prendeville S; Berney DM; Bubendorf L; Compérat E; Egevad L; Hes O; Kristiansen G; Oxley J; van Leenders GJLH; Varma M; van der Kwast T
    Histopathology; 2019 May; 74(6):844-852. PubMed ID: 30604878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal sampling of pelvic lymphadenectomy specimens following radical prostatectomy: is complete tissue submission justified?
    Ni Mhaolcatha S; Power E; Mayer N; Prendeville S
    J Clin Pathol; 2019 Oct; 72(10):712-715. PubMed ID: 31154422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Tissue Submission to Increase Lymph Node Detection in Pelvic Lymph Node Packets Submitted for Patients Undergoing Radical Prostatectomy and Radical Cystectomy.
    Rais-Bahrami S; Tracht JP; McIntosh ER; Lai WS; Gordetsky JB
    Int J Surg Pathol; 2017 Feb; 25(1):12-17. PubMed ID: 27388198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
    Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
    BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hunt for Lymph Nodes: Is Total Submission of Standard-Template and Extended-Template Pelvic Lymph Node Dissections Necessary for Detecting Metastatic Prostate Cancer?
    Gafeer MM; Arriola AGP
    Arch Pathol Lab Med; 2023 Dec; 147(12):1466-1470. PubMed ID: 36881767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
    Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
    Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International society of urological pathology consensus conference on handling and staging of radical prostatectomy specimens.
    Egevad L; Srigley JR; Delahunt B
    Adv Anat Pathol; 2011 Jul; 18(4):301-5. PubMed ID: 21654361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP).
    Lopez-Beltran A; Algaba F; Berney DM; Boccon-Gibod L; Camparo P; Griffiths D; Mikuz G; Montironi R; Varma M; Egevad L
    Histopathology; 2011 Mar; 58(4):579-85. PubMed ID: 21348893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of complete embedding of remaining tissue in gynecological lymph node dissection specimen in surgical pathology on lymph node yield: is it clinically relevant?
    Andruszkow J; Meinhold-Heerlein I; Winkler B; Bruno B; Knüchel R; Jäkel J
    Virchows Arch; 2018 Aug; 473(2):183-188. PubMed ID: 29705969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective assessment of histological serial sectioning of pelvic lymph nodes in prostate cancer: a cost-benefit analysis.
    Schilling D; Hennenlotter J; Gakis G; Schwentner C; Kuehs U; Stenzl A; Sotlar K
    BJU Int; 2012 Sep; 110(6 Pt B):E166-71. PubMed ID: 22314026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complications of pelvic lymphadenectomy in clinically localised prostate cancer: different techniques in comparison and dependency on the number of removed lymph nodes].
    Winter A; Vogt C; Weckermann D; Wawroschek F
    Aktuelle Urol; 2011 May; 42(3):179-83. PubMed ID: 21409742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
    Schiavina R; Manferrari F; Garofalo M; Bertaccini A; Vagnoni V; Guidi M; Borghesi M; Baccos A; Morselli-Labate AM; Concetti S; Martorana G
    BJU Int; 2011 Oct; 108(8):1262-8. PubMed ID: 21446934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seeking a standard for adequate pathologic lymph node staging in primary bladder carcinoma.
    Wang L; Mudaliar K; Mehta V; Barkan GA; Quek ML; Flanigan RC; Picken MM
    Virchows Arch; 2014 May; 464(5):595-602. PubMed ID: 24699919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes.
    Sagalovich D; Calaway A; Srivastava A; Sooriakumaran P; Tewari AK
    BJU Int; 2013 Jan; 111(1):85-94. PubMed ID: 22823452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periprostatic lymph node metastasis in prostate cancer and its clinical significance.
    Deng FM; Mendrinos SE; Das K; Melamed J
    Histopathology; 2012 May; 60(6):1004-8. PubMed ID: 22373012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer.
    Weckermann D; Holl G; Dorn R; Wagner T; Harzmann R
    BJU Int; 2007 May; 99(5):1036-40. PubMed ID: 17437437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node staging in prostate cancer: perspective for the pathologist.
    Prendeville S; van der Kwast TH
    J Clin Pathol; 2016 Dec; 69(12):1039-1045. PubMed ID: 27555432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: a prospective study.
    Vagnoni V; Schiavina R; Romagnoli D; Borghesi M; Passaretti G; Dababneh H; Concetti S; Martorana G
    Urologia; 2012 Dec; 79 Suppl 19():141-6. PubMed ID: 22865337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.